Cash Flow CANbridge Pharmaceuticals Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
16.00
-479.00
-418.00
-562.00
-1,298.00
-950.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
39.00
197.00
31.00
138.00
27.00
51.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-42.00
-134.00
-309.00
-329.00
-709.00
-176.00
Cash Flow from Investing Activities
1.00
15.00
-29.00
-40.00
151.00
-172.00
Cash Flow from Financing Activities
101.00
-18.00
-28.00
-7.00
1,031.00
768.00
Net Cash Inflow / Outflow
60.00
-137.00
-359.00
-328.00
464.00
389.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
7.00
48.00
-10.00
-30.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of CANbridge Pharmaceuticals Inc.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
16.0704673073679
-81.697
97.00
119.67%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
39.4636364138549
-10.145
49.00
489.00%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-42.4992173285075
-54.49
12.00
22.01%
Cash Flow from Investing Activities
1.32854112913522
-145.46
146.00
100.91%
Cash Flow from Financing Activities
101.340032807064
178.635
-77.00
-43.27%
Net Cash Inflow / Outflow
60.8667051350659
-21.545
81.00
382.51%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0.697348527374648
-0.23
0.00
403.20%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is 68.35% vs 56.56% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
-42.50
-134.28
68.35%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
